von Spreckelsen, N., Waldt, N., Poetschke, R., Kesseler, C., Dohmen, H., Jiao, H., . . . Mawrin, C. (2020). KLF4(K409Q)–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment. Acta Neuropathol Commun.
استشهاد بنمط شيكاغوvon Spreckelsen, Niklas, et al. "KLF4(K409Q)–mutated Meningiomas Show Enhanced Hypoxia Signaling and Respond to MTORC1 Inhibitor Treatment." Acta Neuropathol Commun 2020.
MLA استشهادvon Spreckelsen, Niklas, et al. "KLF4(K409Q)–mutated Meningiomas Show Enhanced Hypoxia Signaling and Respond to MTORC1 Inhibitor Treatment." Acta Neuropathol Commun 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.